Literature DB >> 16939939

Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales.

Wen Cao1, Carla Treloar.   

Abstract

The aim of this study was to compare demographic and drug use profiles of non-needle and syringe programmes (NSP) attendees with NSP attendees from the same geographic area. Two data sources were used. One was from an annual national survey of injecting drug users (IDU) at NSP and analysis was restricted to survey sites in Kings Cross and Kogarah in 2003 (NSP survey). The other was from a survey of IDU who do not use NSP as their primary source of injecting equipment within the same broad geographical region (Access survey). Of the total 264 survey participants, 102 had never attended a NSP (non-NSP attendees) and 162 had previous experience of NSP (NSP attendees). Compared with NSP attendees, non-NSP attendees were less likely to report severe drug problems and more likely to report lower prevalence of HIV, hepatitis B and hepatitis C infection. Nevertheless, about 20% of non-NSP attendees reported re-use of needles and syringes after someone else in the previous month. Compared to NSP attendees, a lower rate of usage of health services was reported by non-NSP attendees. Strategies to promote access to NSP and harm reduction services, including testing for blood-borne viruses, information provision and consideration of referral to treatment among non-NSP attendees are recommended.

Entities:  

Mesh:

Year:  2006        PMID: 16939939     DOI: 10.1080/09595230600891282

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  10 in total

1.  Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study.

Authors:  Jenny Iversen; Handan Wand; Libby Topp; John Kaldor; Lisa Maher
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

2.  Patterns of HIV Risks and Related Factors among People Who Inject Drugs in Kermanshah, Iran: A Latent Class Analysis.

Authors:  Hamid Sharifi; Ali Mirzazadeh; Alireza Noroozi; Brandon D L Marshall; Ali Farhoudian; Peter Higgs; Meroe Vameghi; Farahnaz Mohhamadi Shahboulaghi; Mostafa Qorbani; Omid Massah; Bahram Armoon; Mehdi Noroozi
Journal:  J Psychoactive Drugs       Date:  2016-12-12

3.  Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs.

Authors:  Danielle Resiak; Elias Mpofu; Roderick Rothwell
Journal:  Healthcare (Basel)       Date:  2022-04-22

4.  Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting.

Authors:  Dan Werb; Thomas Kerr; Jane Buxton; Jeannie Shoveller; Chris Richardson; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2013-05-01       Impact factor: 4.492

5.  Differences in substance-related risk behavior between dual and triple diagnosed severely mentally ill adults.

Authors:  Michelle Decoux Hampton; Linda Chafetz; Carmen Portillo
Journal:  Ment Health Subst Use       Date:  2011-11-29

6.  Comparing the cost effectiveness of harm reduction strategies: a case study of the Ukraine.

Authors:  Sung Wook Kim; Anni-Maria Pulkki-Brannstrom; Jolene Skordis-Worrall
Journal:  Cost Eff Resour Alloc       Date:  2014-11-24

7.  Injecting and Sexual Networks and Sociodemographic Factors and Dual HIV Risk among People Who Inject Drugs: A Cross-sectional Study in Kermanshah Province, Iran.

Authors:  Mehdi Noroozi; Ali Mirzazadeh; Alireza Noroozi; Hamid Sharifi; Peter Higgs; Zahra Jorjoran-Shushtari; Ali Farhoudian; Farbod Fadai; Farahnaz Mohhamadi-Shahboulaghi; Bahram Armoon; Ahmad Hajebi; Omid Massah
Journal:  Addict Health       Date:  2016-07

8.  Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Kristi Rüütel; Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2009-02-20

Review 9.  Analysis of duration of risk behaviour for key populations: a literature review.

Authors:  Erika Fazito; Paloma Cuchi; Mary Mahy; Tim Brown
Journal:  Sex Transm Infect       Date:  2012-12       Impact factor: 3.519

10.  Hepatitis C avoidance in injection drug users: a typology of possible protective practices.

Authors:  Catherine McGowan; Magdalena Harris; Tim Rhodes
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.